Research ArticleArticle
Evaluation of Health Outcomes with Etanercept Treatment in Patients with Early Nonradiographic Axial Spondyloarthritis
Maxime Dougados, Wen-Chan Tsai, Diego L. Saaibi, Randi Bonin, Jack Bukowski, Ron Pedersen, Bonnie Vlahos and Sameer Kotak
The Journal of Rheumatology August 2015, jrheum.141313; DOI: https://doi.org/10.3899/jrheum.141313
Maxime Dougados
From the Paris Descartes University, Cochin Hospital, Paris, France; Chung-Ho Memorial Hospital, Kaohsiung, Taiwan; Medicity S.A.S., Bucaramanga, Colombia; Pfizer, Collegeville, Pennsylvania; Pfizer, New York, New York, USA. Funded by Pfizer Inc. W. Tsai and D.L. Saaibi were principal investigators for the clinical trial used in this analysis and have received consulting fees unrelated to the development of this manuscript. M. Dougados has received consultancy fees and has participated in symposia organized by Pfizer, both unrelated to the development of this manuscript. R. Bonin, J. Bukowski, R. Pedersen, B. Vlahos, and S. Kotak are employees of Pfizer. Medical writing support was provided by Stephanie Eide of Engage Scientific Solutions and was funded by Pfizer. M. Dougados, MD, President, Clinical Epidemiology and Biostatistics, Paris Descartes University, Cochin Hospital; W.C. Tsai, MD, Division of Rheumatology, Chung-Ho Memorial Hospital; D.L. Saaibi, MD, Medicity S.A.S.; R. Bonin, BS; J. Bukowski, MS, PhD; R. Pedersen, MS; B. Vlahos, MBA, BSN, RN, Director; S. Kotak, MS, MBA, Inflammation and Immunology, Pfizer. Address correspondence to Dr. M. Dougados, Paris Descartes University, Rheumatology Department, Cochin Hospital, Assistance Publique-Hôpitaux de Paris; President, Clinical Epidemiology and Biostatistics, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. E-mail: maxime.dougados@cch.aphp.fr. Accepted for publication June 29, 2015.
Wen-Chan Tsai
From the Paris Descartes University, Cochin Hospital, Paris, France; Chung-Ho Memorial Hospital, Kaohsiung, Taiwan; Medicity S.A.S., Bucaramanga, Colombia; Pfizer, Collegeville, Pennsylvania; Pfizer, New York, New York, USA. Funded by Pfizer Inc. W. Tsai and D.L. Saaibi were principal investigators for the clinical trial used in this analysis and have received consulting fees unrelated to the development of this manuscript. M. Dougados has received consultancy fees and has participated in symposia organized by Pfizer, both unrelated to the development of this manuscript. R. Bonin, J. Bukowski, R. Pedersen, B. Vlahos, and S. Kotak are employees of Pfizer. Medical writing support was provided by Stephanie Eide of Engage Scientific Solutions and was funded by Pfizer. M. Dougados, MD, President, Clinical Epidemiology and Biostatistics, Paris Descartes University, Cochin Hospital; W.C. Tsai, MD, Division of Rheumatology, Chung-Ho Memorial Hospital; D.L. Saaibi, MD, Medicity S.A.S.; R. Bonin, BS; J. Bukowski, MS, PhD; R. Pedersen, MS; B. Vlahos, MBA, BSN, RN, Director; S. Kotak, MS, MBA, Inflammation and Immunology, Pfizer. Address correspondence to Dr. M. Dougados, Paris Descartes University, Rheumatology Department, Cochin Hospital, Assistance Publique-Hôpitaux de Paris; President, Clinical Epidemiology and Biostatistics, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. E-mail: maxime.dougados@cch.aphp.fr. Accepted for publication June 29, 2015.
Diego L. Saaibi
From the Paris Descartes University, Cochin Hospital, Paris, France; Chung-Ho Memorial Hospital, Kaohsiung, Taiwan; Medicity S.A.S., Bucaramanga, Colombia; Pfizer, Collegeville, Pennsylvania; Pfizer, New York, New York, USA. Funded by Pfizer Inc. W. Tsai and D.L. Saaibi were principal investigators for the clinical trial used in this analysis and have received consulting fees unrelated to the development of this manuscript. M. Dougados has received consultancy fees and has participated in symposia organized by Pfizer, both unrelated to the development of this manuscript. R. Bonin, J. Bukowski, R. Pedersen, B. Vlahos, and S. Kotak are employees of Pfizer. Medical writing support was provided by Stephanie Eide of Engage Scientific Solutions and was funded by Pfizer. M. Dougados, MD, President, Clinical Epidemiology and Biostatistics, Paris Descartes University, Cochin Hospital; W.C. Tsai, MD, Division of Rheumatology, Chung-Ho Memorial Hospital; D.L. Saaibi, MD, Medicity S.A.S.; R. Bonin, BS; J. Bukowski, MS, PhD; R. Pedersen, MS; B. Vlahos, MBA, BSN, RN, Director; S. Kotak, MS, MBA, Inflammation and Immunology, Pfizer. Address correspondence to Dr. M. Dougados, Paris Descartes University, Rheumatology Department, Cochin Hospital, Assistance Publique-Hôpitaux de Paris; President, Clinical Epidemiology and Biostatistics, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. E-mail: maxime.dougados@cch.aphp.fr. Accepted for publication June 29, 2015.
Randi Bonin
From the Paris Descartes University, Cochin Hospital, Paris, France; Chung-Ho Memorial Hospital, Kaohsiung, Taiwan; Medicity S.A.S., Bucaramanga, Colombia; Pfizer, Collegeville, Pennsylvania; Pfizer, New York, New York, USA. Funded by Pfizer Inc. W. Tsai and D.L. Saaibi were principal investigators for the clinical trial used in this analysis and have received consulting fees unrelated to the development of this manuscript. M. Dougados has received consultancy fees and has participated in symposia organized by Pfizer, both unrelated to the development of this manuscript. R. Bonin, J. Bukowski, R. Pedersen, B. Vlahos, and S. Kotak are employees of Pfizer. Medical writing support was provided by Stephanie Eide of Engage Scientific Solutions and was funded by Pfizer. M. Dougados, MD, President, Clinical Epidemiology and Biostatistics, Paris Descartes University, Cochin Hospital; W.C. Tsai, MD, Division of Rheumatology, Chung-Ho Memorial Hospital; D.L. Saaibi, MD, Medicity S.A.S.; R. Bonin, BS; J. Bukowski, MS, PhD; R. Pedersen, MS; B. Vlahos, MBA, BSN, RN, Director; S. Kotak, MS, MBA, Inflammation and Immunology, Pfizer. Address correspondence to Dr. M. Dougados, Paris Descartes University, Rheumatology Department, Cochin Hospital, Assistance Publique-Hôpitaux de Paris; President, Clinical Epidemiology and Biostatistics, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. E-mail: maxime.dougados@cch.aphp.fr. Accepted for publication June 29, 2015.
Jack Bukowski
From the Paris Descartes University, Cochin Hospital, Paris, France; Chung-Ho Memorial Hospital, Kaohsiung, Taiwan; Medicity S.A.S., Bucaramanga, Colombia; Pfizer, Collegeville, Pennsylvania; Pfizer, New York, New York, USA. Funded by Pfizer Inc. W. Tsai and D.L. Saaibi were principal investigators for the clinical trial used in this analysis and have received consulting fees unrelated to the development of this manuscript. M. Dougados has received consultancy fees and has participated in symposia organized by Pfizer, both unrelated to the development of this manuscript. R. Bonin, J. Bukowski, R. Pedersen, B. Vlahos, and S. Kotak are employees of Pfizer. Medical writing support was provided by Stephanie Eide of Engage Scientific Solutions and was funded by Pfizer. M. Dougados, MD, President, Clinical Epidemiology and Biostatistics, Paris Descartes University, Cochin Hospital; W.C. Tsai, MD, Division of Rheumatology, Chung-Ho Memorial Hospital; D.L. Saaibi, MD, Medicity S.A.S.; R. Bonin, BS; J. Bukowski, MS, PhD; R. Pedersen, MS; B. Vlahos, MBA, BSN, RN, Director; S. Kotak, MS, MBA, Inflammation and Immunology, Pfizer. Address correspondence to Dr. M. Dougados, Paris Descartes University, Rheumatology Department, Cochin Hospital, Assistance Publique-Hôpitaux de Paris; President, Clinical Epidemiology and Biostatistics, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. E-mail: maxime.dougados@cch.aphp.fr. Accepted for publication June 29, 2015.
Ron Pedersen
From the Paris Descartes University, Cochin Hospital, Paris, France; Chung-Ho Memorial Hospital, Kaohsiung, Taiwan; Medicity S.A.S., Bucaramanga, Colombia; Pfizer, Collegeville, Pennsylvania; Pfizer, New York, New York, USA. Funded by Pfizer Inc. W. Tsai and D.L. Saaibi were principal investigators for the clinical trial used in this analysis and have received consulting fees unrelated to the development of this manuscript. M. Dougados has received consultancy fees and has participated in symposia organized by Pfizer, both unrelated to the development of this manuscript. R. Bonin, J. Bukowski, R. Pedersen, B. Vlahos, and S. Kotak are employees of Pfizer. Medical writing support was provided by Stephanie Eide of Engage Scientific Solutions and was funded by Pfizer. M. Dougados, MD, President, Clinical Epidemiology and Biostatistics, Paris Descartes University, Cochin Hospital; W.C. Tsai, MD, Division of Rheumatology, Chung-Ho Memorial Hospital; D.L. Saaibi, MD, Medicity S.A.S.; R. Bonin, BS; J. Bukowski, MS, PhD; R. Pedersen, MS; B. Vlahos, MBA, BSN, RN, Director; S. Kotak, MS, MBA, Inflammation and Immunology, Pfizer. Address correspondence to Dr. M. Dougados, Paris Descartes University, Rheumatology Department, Cochin Hospital, Assistance Publique-Hôpitaux de Paris; President, Clinical Epidemiology and Biostatistics, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. E-mail: maxime.dougados@cch.aphp.fr. Accepted for publication June 29, 2015.
Bonnie Vlahos
From the Paris Descartes University, Cochin Hospital, Paris, France; Chung-Ho Memorial Hospital, Kaohsiung, Taiwan; Medicity S.A.S., Bucaramanga, Colombia; Pfizer, Collegeville, Pennsylvania; Pfizer, New York, New York, USA. Funded by Pfizer Inc. W. Tsai and D.L. Saaibi were principal investigators for the clinical trial used in this analysis and have received consulting fees unrelated to the development of this manuscript. M. Dougados has received consultancy fees and has participated in symposia organized by Pfizer, both unrelated to the development of this manuscript. R. Bonin, J. Bukowski, R. Pedersen, B. Vlahos, and S. Kotak are employees of Pfizer. Medical writing support was provided by Stephanie Eide of Engage Scientific Solutions and was funded by Pfizer. M. Dougados, MD, President, Clinical Epidemiology and Biostatistics, Paris Descartes University, Cochin Hospital; W.C. Tsai, MD, Division of Rheumatology, Chung-Ho Memorial Hospital; D.L. Saaibi, MD, Medicity S.A.S.; R. Bonin, BS; J. Bukowski, MS, PhD; R. Pedersen, MS; B. Vlahos, MBA, BSN, RN, Director; S. Kotak, MS, MBA, Inflammation and Immunology, Pfizer. Address correspondence to Dr. M. Dougados, Paris Descartes University, Rheumatology Department, Cochin Hospital, Assistance Publique-Hôpitaux de Paris; President, Clinical Epidemiology and Biostatistics, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. E-mail: maxime.dougados@cch.aphp.fr. Accepted for publication June 29, 2015.
Sameer Kotak
From the Paris Descartes University, Cochin Hospital, Paris, France; Chung-Ho Memorial Hospital, Kaohsiung, Taiwan; Medicity S.A.S., Bucaramanga, Colombia; Pfizer, Collegeville, Pennsylvania; Pfizer, New York, New York, USA. Funded by Pfizer Inc. W. Tsai and D.L. Saaibi were principal investigators for the clinical trial used in this analysis and have received consulting fees unrelated to the development of this manuscript. M. Dougados has received consultancy fees and has participated in symposia organized by Pfizer, both unrelated to the development of this manuscript. R. Bonin, J. Bukowski, R. Pedersen, B. Vlahos, and S. Kotak are employees of Pfizer. Medical writing support was provided by Stephanie Eide of Engage Scientific Solutions and was funded by Pfizer. M. Dougados, MD, President, Clinical Epidemiology and Biostatistics, Paris Descartes University, Cochin Hospital; W.C. Tsai, MD, Division of Rheumatology, Chung-Ho Memorial Hospital; D.L. Saaibi, MD, Medicity S.A.S.; R. Bonin, BS; J. Bukowski, MS, PhD; R. Pedersen, MS; B. Vlahos, MBA, BSN, RN, Director; S. Kotak, MS, MBA, Inflammation and Immunology, Pfizer. Address correspondence to Dr. M. Dougados, Paris Descartes University, Rheumatology Department, Cochin Hospital, Assistance Publique-Hôpitaux de Paris; President, Clinical Epidemiology and Biostatistics, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. E-mail: maxime.dougados@cch.aphp.fr. Accepted for publication June 29, 2015.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Evaluation of Health Outcomes with Etanercept Treatment in Patients with Early Nonradiographic Axial Spondyloarthritis
Maxime Dougados, Wen-Chan Tsai, Diego L. Saaibi, Randi Bonin, Jack Bukowski, Ron Pedersen, Bonnie Vlahos, Sameer Kotak
The Journal of Rheumatology Aug 2015, jrheum.141313; DOI: 10.3899/jrheum.141313
Evaluation of Health Outcomes with Etanercept Treatment in Patients with Early Nonradiographic Axial Spondyloarthritis
Maxime Dougados, Wen-Chan Tsai, Diego L. Saaibi, Randi Bonin, Jack Bukowski, Ron Pedersen, Bonnie Vlahos, Sameer Kotak
The Journal of Rheumatology Aug 2015, jrheum.141313; DOI: 10.3899/jrheum.141313